Literature DB >> 8806858

Enhanced expression of bax in small preantral follicles during 4-vinylcyclohexene diepoxide-induced ovotoxicity in the rat.

L N Springer1, J L Tilly, I G Sipes, P B Hoyer.   

Abstract

4-Vinylcyclohexene diepoxide (VCD) destroys small preantral (25-100 microns) ovarian follicles after repeated dosing in mice and rats. A previous study determined this follicular destruction is via apoptosis (physiological cell death). The purposes of this study were to examine the effects of VCD on amounts of mRNA for several genes that might be involved in this ovotoxic response and to determine the specificity of this response for small preantral follicles. The genes of interest were bax, a cell death gene; three forms of the antioxidant enzyme, superoxide dismutase (mitochondrial manganese-containing or MnSOD, cytosolic copper/zinc-containing or Cu/ZnSOD, and secreted or secSOD); and microsomal epoxide hydrolase (mEH), involved in detoxification of VCD. Female Fischer 344 rats were administered daily doses (10 days) of vehicle control (sesame oil) or VCD (80 mg/kg, ip). Four hours after the last injection, livers and ovaries were removed. Small (25-100 microns) and large (100-250 microns) preantral follicles were separated from the ovaries by gentle dissociation and collected by mouth pipeting. Total RNA was extracted from all tissues, reverse transcribed into first-strand cDNA, and amplified by polymerase chain reaction using oligonucleotide primers specific for each gene. Relative levels of mRNA were visualized by agarose gel electrophoresis and autoradiography and quantified by densitometric analysis. Coamplification of ribosomal protein L19 (constitutively expressed in ovarian tissue) was used for normalization in each sample. Increased levels of mRNA for bax (172 +/- 20% of control, p < 0.05), MnSOD (248 +/- 70% of control, p < 0.05), and mEH (352 +/- 120% of control, p < 0.05) were measured in 25- to 100-microns follicles collected from VCD-treated compared with control rats. Unlike 25- to 100-microns follicles (the targets of ovotoxicity), in 100- to 250-microns follicles (nontargets) there were no changes (p > 0.05) in mRNA levels for bax or MnSOD in VCD-treated rats; however, mRNA levels for mEH were significantly decreased (79 +/- 4% of control, p < 0.05), compared with control. No changes in levels of mRNA for mEH were observed in liver from VCD-treated rats relative to control. Additionally, in liver VCD caused a significant decrease in mRNA levels for bax (31 +/- 5% of control, p < 0.05) and Cu-ZnSOD (56 +/- 17% of control, p < 0.05). In summary, dosing of rats with VCD enhanced expression of mRNA encoding several genes that might respond during the induction of ovotoxicity. The selective increase in bax in the population of follicles destroyed by repeated dosing with VCD may reflect their susceptibility to apoptosis.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8806858     DOI: 10.1006/taap.1996.0181

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN: 0041-008X            Impact factor:   4.219


  23 in total

1.  Inhibition of PIK3 signaling pathway members by the ovotoxicant 4-vinylcyclohexene diepoxide in rats.

Authors:  Aileen F Keating; Shannon M Fernandez; Connie J Mark-Kappeler; Nivedita Sen; I Glenn Sipes; Patricia B Hoyer
Journal:  Biol Reprod       Date:  2010-11-10       Impact factor: 4.285

Review 2.  Impact of environmental exposures on ovarian function and role of xenobiotic metabolism during ovotoxicity.

Authors:  Poulomi Bhattacharya; Aileen F Keating
Journal:  Toxicol Appl Pharmacol       Date:  2012-04-13       Impact factor: 4.219

3.  Glutathione S-transferase class μ regulation of apoptosis signal-regulating kinase 1 protein during VCD-induced ovotoxicity in neonatal rat ovaries.

Authors:  Poulomi Bhattacharya; Jill A Madden; Nivedita Sen; Patricia B Hoyer; Aileen F Keating
Journal:  Toxicol Appl Pharmacol       Date:  2012-12-27       Impact factor: 4.219

4.  Inhibition of ovarian KIT phosphorylation by the ovotoxicant 4-vinylcyclohexene diepoxide in rats.

Authors:  Connie J Mark-Kappeler; Nivedita Sen; Ashley Lukefahr; Laurel McKee; I Glenn Sipes; John Konhilas; Patricia B Hoyer
Journal:  Biol Reprod       Date:  2011-06-15       Impact factor: 4.285

Review 5.  Roles of reactive oxygen species and antioxidants in ovarian toxicity.

Authors:  Patrick J Devine; Sally D Perreault; Ulrike Luderer
Journal:  Biol Reprod       Date:  2012-02-09       Impact factor: 4.285

6.  Cognitive changes across the menopause transition: A longitudinal evaluation of the impact of age and ovarian status on spatial memory.

Authors:  Stephanie V Koebele; Sarah E Mennenga; Ryoko Hiroi; Alicia M Quihuis; Lauren T Hewitt; Mallori L Poisson; Christina George; Loretta P Mayer; Cheryl A Dyer; Leona S Aiken; Laurence M Demers; Catherine Carson; Heather A Bimonte-Nelson
Journal:  Horm Behav       Date:  2016-10-26       Impact factor: 3.587

7.  Neuroprotection against excitotoxic brain injury in mice after ovarian steroid depletion.

Authors:  P Elyse Schauwecker; Ruth I Wood; Ariana Lorenzana
Journal:  Brain Res       Date:  2009-02-21       Impact factor: 3.252

8.  Dioxin exposure reduces the steroidogenic capacity of mouse antral follicles mainly at the level of HSD17B1 without altering atresia.

Authors:  Bethany N Karman; Mallikarjuna S Basavarajappa; Patrick Hannon; Jodi A Flaws
Journal:  Toxicol Appl Pharmacol       Date:  2012-08-06       Impact factor: 4.219

9.  Effect of phosphatidylinositol-3 kinase inhibition on ovotoxicity caused by 4-vinylcyclohexene diepoxide and 7, 12-dimethylbenz[a]anthracene in neonatal rat ovaries.

Authors:  Aileen F Keating; Connie J Mark; Nivedita Sen; I Glenn Sipes; Patricia B Hoyer
Journal:  Toxicol Appl Pharmacol       Date:  2009-08-18       Impact factor: 4.219

10.  Effect of CYP2E1 gene deletion in mice on expression of microsomal epoxide hydrolase in response to VCD exposure.

Authors:  Aileen F Keating; Kathila S Rajapaksa; I Glenn Sipes; Patricia B Hoyer
Journal:  Toxicol Sci       Date:  2008-07-12       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.